Literature DB >> 11075927

Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum.

P R August1, T H Grossman, C Minor, M P Draper, I A MacNeil, J M Pemberton, K M Call, D Holt, M S Osburne.   

Abstract

Violacein is a purple-colored, broad-spectrum antibacterial pigment that has a dimeric structure composed of 5-hydroxyindole, oxindole and 2-pyyrolidone subunits formed by the condensation of two modified tryptophan molecules. The violacein biosynthetic gene cluster from Chromobacterium violaceum was characterized by DNA sequencing, transposon mutagenesis, and chemical analysis of the pathway intermediates produced heterologously in Escherichia. coli. The violacein biosynthetic gene cluster spans eight kilobases and is comprised of the four genes, vioABCD, that are necessary for violacein production. Sequence analysis suggests that the products of vioA, vioC and vioD are nucleotide-dependent monooxygenases. Disruption of vioA or vioB completely abrogates the biosynthesis of violacein intermediates, while disruption of the vioC or vioD genes results in the production of violacein precursors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11075927

Source DB:  PubMed          Journal:  J Mol Microbiol Biotechnol        ISSN: 1464-1801


  41 in total

Review 1.  Metagenomics: application of genomics to uncultured microorganisms.

Authors:  Jo Handelsman
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

2.  Expression, crystallization and preliminary crystallographic data analysis of VioD, a hydroxylase in the violacein-biosynthesis pathway.

Authors:  Tingting Ran; Mengxiao Gao; Qiaoe Wei; Jianhua He; Lin Tang; Weiwu Wang; Dongqing Xu
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

3.  The violacein biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins.

Authors:  Katherine S Ryan; Carl J Balibar; Kaitlyn E Turo; Christopher T Walsh; Catherine L Drennan
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

4.  Fatal wound infection caused by Chromobacterium violaceum in Ho Chi Minh City, Vietnam.

Authors:  Stephen Baker; James I Campbell; Richard Stabler; Hoang V M Nguyen; Diep S To; Dung V Nguyen; Jeremy Farrar
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

Review 5.  Metagenomic approaches to natural products from free-living and symbiotic organisms.

Authors:  Sean F Brady; Luke Simmons; Jeffrey H Kim; Eric W Schmidt
Journal:  Nat Prod Rep       Date:  2009-09-16       Impact factor: 13.423

6.  Inhibition of quorum sensing in Chromobacterium violaceum by Syzygium cumini L. and Pimenta dioica L.

Authors:  Halkare Suryanarayana Vasavi; Ananthapadmanabha Bhagwath Arun; Punchapady Devasya Rekha
Journal:  Asian Pac J Trop Biomed       Date:  2013-12

7.  Diversity in antifungal activity of strains of Chromobacterium violaceum from the Brazilian Amazon.

Authors:  Eriana Serpa Barreto; Adalgisa Ribeiro Torres; Marliton Rocha Barreto; Ana Tereza Ribeiro Vasconcelos; Spartaco Astolfi-Filho; Mariangela Hungria
Journal:  J Ind Microbiol Biotechnol       Date:  2008-03-18       Impact factor: 3.346

8.  Biosynthesis of Violacein, Structure and Function of l-Tryptophan Oxidase VioA from Chromobacterium violaceum.

Authors:  Janis J Füller; René Röpke; Joern Krausze; Kim E Rennhack; Nils P Daniel; Wulf Blankenfeldt; Stefan Schulz; Dieter Jahn; Jürgen Moser
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

9.  Novel pathway of salicylate degradation by Streptomyces sp. strain WA46.

Authors:  Daisuke Ishiyama; Dusica Vujaklija; Julian Davies
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

10.  Violacein-producing Collimonas sp. from the sea surface microlayer of costal waters in Trøndelag, Norway.

Authors:  Sigrid Hakvåg; Espen Fjaervik; Geir Klinkenberg; Sven Even F Borgos; Kjell D Josefsen; Trond E Ellingsen; Sergey B Zotchev
Journal:  Mar Drugs       Date:  2009-11-12       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.